Forskning ved Københavns Universitet - Københavns Universitet

Forside

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. / Andersson, C; Olesen, JB; Hansen, PR; Weeke, P; Nørgaard, ML; Jørgensen, CH; Lange, Theis; Abildstrøm, Steen Zabell; Schramm, TK; Vaag, A; Køber, Lars Valeur; Torp-Pedersen, C; Gislason, GH.

I: Diabetologia, Bind 53, Nr. 12, 2010, s. 2546-2553.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Andersson, C, Olesen, JB, Hansen, PR, Weeke, P, Nørgaard, ML, Jørgensen, CH, Lange, T, Abildstrøm, SZ, Schramm, TK, Vaag, A, Køber, LV, Torp-Pedersen, C & Gislason, GH 2010, 'Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study', Diabetologia, bind 53, nr. 12, s. 2546-2553. https://doi.org/10.1007/s00125-010-1906-6

APA

Andersson, C., Olesen, JB., Hansen, PR., Weeke, P., Nørgaard, ML., Jørgensen, CH., ... Gislason, GH. (2010). Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia, 53(12), 2546-2553. https://doi.org/10.1007/s00125-010-1906-6

Vancouver

Andersson C, Olesen JB, Hansen PR, Weeke P, Nørgaard ML, Jørgensen CH o.a. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia. 2010;53(12):2546-2553. https://doi.org/10.1007/s00125-010-1906-6

Author

Andersson, C ; Olesen, JB ; Hansen, PR ; Weeke, P ; Nørgaard, ML ; Jørgensen, CH ; Lange, Theis ; Abildstrøm, Steen Zabell ; Schramm, TK ; Vaag, A ; Køber, Lars Valeur ; Torp-Pedersen, C ; Gislason, GH. / Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. I: Diabetologia. 2010 ; Bind 53, Nr. 12. s. 2546-2553.

Bibtex

@article{0d6ad97757b546c38233cfbc1a95f120,
title = "Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study",
abstract = "The safety of metformin in heart failure has been questioned because of a perceived risk of life-threatening lactic acidosis, though recent studies have not supported this concern. We investigated the risk of all-cause mortality associated with individual glucose-lowering treatment regimens used in current clinical practice in Denmark.",
author = "C Andersson and JB Olesen and PR Hansen and P Weeke and ML N{\o}rgaard and CH J{\o}rgensen and Theis Lange and Abildstr{\o}m, {Steen Zabell} and TK Schramm and A Vaag and K{\o}ber, {Lars Valeur} and C Torp-Pedersen and GH Gislason",
year = "2010",
doi = "10.1007/s00125-010-1906-6",
language = "English",
volume = "53",
pages = "2546--2553",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

AU - Andersson, C

AU - Olesen, JB

AU - Hansen, PR

AU - Weeke, P

AU - Nørgaard, ML

AU - Jørgensen, CH

AU - Lange, Theis

AU - Abildstrøm, Steen Zabell

AU - Schramm, TK

AU - Vaag, A

AU - Køber, Lars Valeur

AU - Torp-Pedersen, C

AU - Gislason, GH

PY - 2010

Y1 - 2010

N2 - The safety of metformin in heart failure has been questioned because of a perceived risk of life-threatening lactic acidosis, though recent studies have not supported this concern. We investigated the risk of all-cause mortality associated with individual glucose-lowering treatment regimens used in current clinical practice in Denmark.

AB - The safety of metformin in heart failure has been questioned because of a perceived risk of life-threatening lactic acidosis, though recent studies have not supported this concern. We investigated the risk of all-cause mortality associated with individual glucose-lowering treatment regimens used in current clinical practice in Denmark.

U2 - 10.1007/s00125-010-1906-6

DO - 10.1007/s00125-010-1906-6

M3 - Journal article

C2 - 20838985

VL - 53

SP - 2546

EP - 2553

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 12

ER -

ID: 34205257